» Articles » PMID: 6304177

Cyclic Adenosine Monophosphate Effects on the Myocardium: a Man Who Blows Hot and Cold with One Breath

Overview
Date 1983 Jul 1
PMID 6304177
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Agents that increase cellular cyclic adenosine monophosphate (cyclic AMP) levels exert several effects on cardiac function. These include increases in heart rate and both the force of contraction and rate of relaxation. The latter effects, which might appear to be contradictory, actually represent essential components of the response needed to allow the heart to increase its stroke volume when heart rate is accelerated. This article reviews the mechanisms by which cyclic AMP exerts both contraction-promoting and relaxation-promoting effects in the integrated response of the heart to sympathetic stimulation.

Citing Articles

Hemodynamic effects and tolerance of dobutamine for myocardial dysfunction during septic shock: An observational multicenter prospective echocardiographic study.

Razazi K, Labbe V, Laine L, Bedet A, Carteaux G, de Prost N Front Cardiovasc Med. 2022; 9:951016.

PMID: 36158835 PMC: 9500364. DOI: 10.3389/fcvm.2022.951016.


Mouse Cardiac Pde1C Is a Direct Transcriptional Target of Pparα.

Shete V, Liu N, Jia Y, Viswakarma N, Reddy J, Thimmapaya B Int J Mol Sci. 2018; 19(12).

PMID: 30469494 PMC: 6321386. DOI: 10.3390/ijms19123704.


Dobutamine as bridge to angiotensin-converting enzyme inhibitor-nitrate therapy in endstage heart failure.

Levine T, Levine A, ELLIOTT W, Narins B, Stomel R Clin Cardiol. 2001; 24(3):231-6.

PMID: 11288970 PMC: 6654832. DOI: 10.1002/clc.4960240311.


Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure.

Fitton A, Brogden R Drugs Aging. 1994; 4(5):417-41.

PMID: 8043944 DOI: 10.2165/00002512-199404050-00007.


Effects of alpha-adrenoceptor stimulation with phenylephrine in the presence of propranolol on force of contraction, slow inward current and cyclic AMP content in the bovine heart.

Bruckner R, Scholz H Br J Pharmacol. 1984; 82(1):223-32.

PMID: 6329389 PMC: 1987239. DOI: 10.1111/j.1476-5381.1984.tb16462.x.